Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Equity (2024 - 2025)

Inhibrx Biosciences (INBX) has disclosed Return on Equity for 2 consecutive years, with 2.94% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 1121.0% to 2.94% in Q3 2025 year-over-year; TTM through Sep 2025 was 2.94%, a 1121.0% decrease, with the full-year FY2024 number at 19.06%, changed N/A from a year prior.
  • Return on Equity was 2.94% for Q3 2025 at Inhibrx Biosciences, down from 2.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 15.11% in Q1 2025 to a low of 9.49% in Q1 2024.